Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population

Breast Journal

Volumn 13, Issue 2, 2007, Pages 115-121

  Worsham, Maria J ^a,c,e   Abrams, Judith ^b   Raju, Usha ^c   Kapke, Alissa ^c   Lu, Mei ^c   Cheng, Jingfang ^a   Mott, Donna ^b   Wolman, Sandra R ^d  

^a HENRY FORD HOSPITAL   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c Department of Pathology ^*  (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Atypical ductal hyperplasia (ADH); Atypical lobular hyperplasia (ALH); Benign breast disease; Incidence rate (IR); Nonproliferative; Proliferative

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; POISSON DISTRIBUTION; RISK ASSESSMENT; TUMOR BIOPSY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BIOPSY; BREAST; BREAST DISEASES; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; INCIDENCE; MICHIGAN; MIDDLE AGED; PRIMARY HEALTH CARE; REGISTRIES; REGRESSION ANALYSIS;

EID: 33847134827     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00388.x     Document Type: Article

References (30)

1. Kalache A. Risk factors for breast cancer: a tabular summary of the epidemiological literature. Br J Surg 1981;68:797-99.
2. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975;55:231-73.
3. Black M. In situ carcinoma of the breast. Pathol Annu 1969;4:185-210.
4. Haagensen CD. Breast Carcinoma Risk and Detection. Philadelphia: W.B Saunders, 1981: 70-75.
5. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-708.
6. Black MM, Barclay TH, Cutler SJ, Hankey BF, Asire AJ. Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 1972;29:338-43.
7. Kodlin D, Winger EE, Morgenstern NL, Chen U. Chronic mastopathy and breast cancer. A follow-up study. Cancer 1977;39:2603-07.
8. Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978;61:1055-63.
9. Hutter RVP. Consensus meeting: is "fibrocystic disease" of the breast precancerous Arch Pathol Lab Med 1986;110:171-73.
10. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998;122:1053-55.
11. Davis HH, Simons M, Davis JB. Cystic Disease of the Breast: Relationship to Carcinoma. Cancer 1964;17:957-78.
12. MacMahon B, Cole P, Brown J. Etiology of human breast cancer. A review. J Natl Cancer Inst 1973;50:21-42.
13. Donnelly PK, Baker KW, Carney JA, O'Fallon WM. Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota. Mayo Clin Proc 1975;50:21-42.
14. Monson RR, Yen S, MacMahon B, Warren S. Chronic mastitis and carcinoma of the breast. Lancet 1976;2:224-26.
15. Kodlin D, Winger EE, Morganstein NL, Chen U. Chronic mastopathy and breasr cancer. A follow-up study. Cancer 1977;39:2603-07.
16. Page DL, Vander Zwaag R, Rogers LW, Will1iams LT, Walker WE, Hartman WH. Relation betwen component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978;61:1055-63.
17. Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B. Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 1980;65:13-20.
18. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:3229-37.
19. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135:619-31.
20. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988;128:467-77.
21. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-44.
22. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-65.
23. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-36.
24. Dupont WD, Page DL, Parl FF, et al. Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 1999;85:1277-83.
25. Byrne C, Connolly JL, Colditz GA, Schnitt SJ. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer 2000;89:2046-52.
26. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-15.
27. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
28. Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 2004;96:616-20.
29. Tamimi RM, Byrne C, Baer HJ, et al. Benign breast disease, recent alcohol consumption, and risk of breast cancer: a nested case-control study. Breast Cancer Res 2005;7:R555-62.
30. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003;53:342-55.